3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Glioblastoma
3
Advanced Solid Tumours
3
Solid Tumors
2
Advanced Malignant Solid Neoplasm
2
Triple-negative Metastatic Breast Cancer
1
Triple Negative Breast Neoplasms
1
Rhabdomyosarcoma
1
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
1
Pinealoma
1
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Metastatic Pancreatic Adenocarcinoma
1
Medulloblastoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gliosarcoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Chromosome 5q Deletion Syndrome
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Astrocytoma
1
Interventions
Cisplatin
12
Radiotherapy
10
Cetuximab
9
Fluorouracil
6
Drug Therapy
5
Docetaxel
5
pembrolizumab
3
Radiotherapy, Intensity-Modulated
3
Radiation
3
Laser Therapy
3
Hydroxyurea
3
sargramostim
2
Surveys and Questionnaires
2
Resistance Training
2
Psychiatric Rehabilitation
2
Nutritional Status
2
Nicotine
2
Counseling
2
Celecoxib
2
Carboplatin
2
Bupropion
2
Bronchoscopy
2
sodium thiosulfate
1
motexafin gadolinium
1
gossypol acetic acid
1
durvalumab
1
adavosertib
1
Zinc Oxide
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Laryngeal Neoplasms
×
adavosertib
×
Clear all
NCT03028766
2024-09-19
WISTERIA
University of Birmingham
Phase 1
Completed
9 enrolled